Yourgene Health Launches LightBench Detect for Fetal Fraction Enrichment
Manchester, UK - Yourgene Health plc, a leading international molecular diagnostics group, announces the launch of the LightBench® Detect, the latest addition to its Ranger® Technology instrumentation portfolio at the 26th International Conference on Prenatal Diagnosis and Therapy (ISPD).
Early diagnosis of Cancer - myth or reality?
Early diagnosis of cancer - myth or reality?
‘Keep your cool’ – advice for men wanting to be fathers
There are many ways to improve sperm health, advises specialist in male fertility ahead of Father’s Day .
The elephant in the room: addressing device development challenges early on
Andrea Pybus says: I’ve often heard colleagues say that it would be the ‘challenge we didn’t anticipate, that catches us out’. I have certainly experienced this. But more often than not, the challenges or ‘project killers’ I have witnessed were identified early in the medical device programme. In this blog I discuss the reasons why unanswered questions asked at the start of a project can get…
Four steps to selecting the right device to deliver therapies
Charlotte Harris, Head of Front End Innovation at Team Consulting, discusses four steps that have to be taken when selecting the right drug delivery device for your chosen therapy.
See you in Vegas?
The Marcus Evans Medical Device Manufacturing and R&D Summit will be live in Las Vegas from the 23rd-24th of June and we can’t wait to see you there.
Arecor announces exclusive collaboration with a top 5 global pharmaceutical company
Cambridge, UK - Arecor Therapeutics plc, the biopharmaceutical group advancing today’s therapies to enable healthier lives, announces that it has signed an exclusive formulation study collaboration with a top five global pharmaceutical company.
Global Access Diagnostics (GADx) formed to expand affordable access to advanced rapid diagnostic technologies
Bedford, UK - Global Access Health (GAH), a social enterprise dedicated to providing affordable medical products for global health, formally introduces its first portfolio company, Global Access Diagnostics (GADx). GADx has been created to address gaps in the global provision of diagnostics with a focus on expanding affordable access to quality tests.
seqWell appoints Dr Amy Liao to Board of Directors
Beverly, Mass – seqWell, a global provider of genomic library workflow solutions including the plexWell™ next-generation sequencing (NGS) multiplexing technology, announces the appointment of Dr Amy Liao to its Board. Amy joins the current Board of Directors, led by Chairman Paul McEwan. The appointment supports the commercial development of the Company’s existing and future products, following…
Spirea raises £2.4M ($3M) to develop antibody drug conjugates in cancer
Cambridge - Spirea Limited, a Cambridge company created to advance a new generation of antibody drug conjugate (ADC) therapeutics, has announced that it has secured funding of £2.4 million with investments from high-profile UK and US investors. Spirea will use the funds to initiate its pipeline of superior and differentiated ADCs in the treatment of solid tumours where there is a high unmet need.
Tackling the challenges of cloud connectivity
In a new article for ONdrugDelivery, Gabrielle Whitworth-Smith and Thomas Watts consider the various challenges of building cloud connectivity into your medical device platform.
How digital UX in clinical trials can improve measures
Implementing Digital health technologies effectively can be challenging. In a new article for ONdrugDelivery, Ben Cox, Head of Digital Design, discusses how adopting a UX approach when designing digital tools can lead to more meaningful measures.
Evonetix appoints Colin McCracken as Chief Executive Officer
Cambridge, UK - EVONETIX LTD (‘Evonetix’), the synthetic biology company bringing semiconductor technology to DNA synthesis, announces the appointment of Colin McCracken as Chief Executive Officer with immediate effect. Colin’s appointment will support the next phase of the Company’s development and the commercialisation of its semiconductor-based DNA synthesis platform.
Bio-Rad Launches Foresight Pro Columns for Biotherapeutic Production
Helcules, Calif. - Bio-Rad Laboratories, Inc., a global leader of life science research and clinical diagnostic products, announces the launch of its CHT™ prepacked Foresight Pro Columns, designed to support downstream process-scale chromatography applications across different stages of biological drug development and production.
Innovate UK awards grant to Orbit Discovery to expand high throughput cell-based functional screening platform capabilities in peptide drug discovery
The project will use microfluidic technology to improve efficiency of peptide therapeutics discovery for challenging drug targets.
More lab space snapped up at The Epicentre, Haverhill
Five new dedicated laboratory spaces at The EpiCentre in Haverhill have been snapped up before completion, due to the rapid upsurge in demand for biotech and life sciences laboratories in the Cambridgeshire area.
2 years after Germany's regulation For digital health apps, what can we learn?
At the end of 2019, the Digital Healthcare Act (Digitales Versorgungsgesetz, DVG) introduced a dedicated pathway enabling reimbursement of digital health offerings in Germany, bringing more transparency into the approval process for manufacturers, physicians, and patients.
Nuffield Health Cambridge Hospital announces patient-centred approach to care with the launch of Cambridge Reflux Service
A new private clinic led by three prominent consultants will provide a multi-disciplinary approach to patient care as Nuffield Health Cambridge Hospital becomes the first to perform Stretta therapy in the East of England. Leading the new specialist Cambridge Reflux Service at Nuffield Health Cambridge Hospital are Dr Corbett, Mr Hindmarsh and Mr Sujendran, pictured.
What to do when an employee can’t return from holiday as planned
Employers may find out that an employee is stranded abroad due to recent flight cancellations, unable to return to work from their holiday as planned. If this is the first time this has happened, you may be wondering how best to manage this situation.
Herpes Simplex Virus vaccines - a much needed renaissance
This month VacZine Analytics, a UK-based strategic research publisher exclusively focused on vaccines and infectious diseases, releases new forecasts and global commercial opportunity analyses for prophylactic and therapeutic Herpes simplex virus (HSV) vaccines.
Metrion Biosciences appoints Dr Benedetta Montagnini as Head of European Business Development
Expansion of European business development team supports next phase of growth for Metrion’s ion channel drug discovery services
Four for the price of five
Trials start this week for a four-day week. If successful, will it just change our schedule or how we think about change itself?
Developing an effective staff retention strategy: why personalisation is the key
Right now, employees hold all the cards. At least that’s what I’m hearing every day from my clients in businesses both large and small. With the UK facing a skills shortage, too many companies are chasing too few employees, and as a result, many tell me they’re struggling to attract the right calibre of candidates to fill their vacancies.
Optibrium expands UK head office with new facilities on Cambridge Innovation Park
Optibrium™, a developer of software for drug discovery, announces the expansion of its UK headquarters with a move to larger office premises on Cambridge Innovation Park North. The new facilities accommodate Optibrium's accelerated growth and ongoing recruitment efforts to support the continued success and development of the company's innovative technology focused on improving the efficiency and…
Axol Bioscience introduces CiPA-validated human stem cell-derived ventricular cardiomyocytes to help improve drug discovery
Cambridge and Edinburgh, UK - Axol Bioscience Ltd., an established provider of iPSC-derived cells, media, and characterization services for life science discovery, announces that its human induced pluripotent stem cell (iPSC)-derived ventricular cardiomyocytes have undergone comprehensive in vitro pro-arrhythmia assay (CiPA) validation. Using this assay, the cells were shown to be suitable for…